Antonis Fanouriakis

7.2k total citations · 1 hit paper
112 papers, 2.1k citations indexed

About

Antonis Fanouriakis is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Antonis Fanouriakis has authored 112 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Rheumatology, 47 papers in Immunology and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Antonis Fanouriakis's work include Systemic Lupus Erythematosus Research (90 papers), Atherosclerosis and Cardiovascular Diseases (29 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Antonis Fanouriakis is often cited by papers focused on Systemic Lupus Erythematosus Research (90 papers), Atherosclerosis and Cardiovascular Diseases (29 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Antonis Fanouriakis collaborates with scholars based in Greece, Cyprus and United States. Antonis Fanouriakis's co-authors include Dimitrios T. Boumpas, George Βertsias, Nikolaos Tziolos, Prodromos Sidiropoulos, Dionysis Nikolopoulos, Cristina Pamfil, Argyro Repa, Ivan Padjen, Alessia Alunno and Irini Gergianaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Medicine and Science Advances.

In The Last Decade

Antonis Fanouriakis

99 papers receiving 2.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Update οn the diagnosis and management of systemic lupus erythematosus

2020 434 citations Antonis Fanouriakis, Nikolaos Tziolos et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonis Fanouriakis Greece	25	1.7k	1.1k	376	312	279	112	2.1k
Alberta Hoi Australia	23	1.9k 1.1×	1.7k 1.6×	433 1.2×	313 1.0×	103 0.4×	79	2.7k
H. Michael Belmont United States	24	1.4k 0.8×	990 0.9×	270 0.7×	210 0.7×	135 0.5×	74	2.1k
Enrique de Ramón Spain	20	2.1k 1.3×	1.3k 1.2×	478 1.3×	650 2.1×	221 0.8×	51	3.1k
María José Cuadrado United Kingdom	31	2.5k 1.5×	680 0.6×	253 0.7×	316 1.0×	474 1.7×	55	3.3k
J Rovenský Slovakia	15	1.4k 0.8×	534 0.5×	179 0.5×	236 0.8×	149 0.5×	47	2.2k
Gabriella Morozzi Italy	23	962 0.6×	492 0.5×	385 1.0×	264 0.8×	133 0.5×	57	1.4k
Andreas Jönsen Sweden	37	2.6k 1.6×	2.5k 2.4×	638 1.7×	417 1.3×	137 0.5×	105	3.9k
Robert Roubey United States	29	2.3k 1.4×	1.3k 1.2×	748 2.0×	156 0.5×	108 0.4×	62	3.4k
Gyula Szegedi Hungary	30	1.4k 0.8×	873 0.8×	249 0.7×	657 2.1×	88 0.3×	96	2.6k
Gráinne Murphy Ireland	15	771 0.5×	598 0.6×	243 0.6×	181 0.6×	46 0.2×	38	1.4k

Countries citing papers authored by Antonis Fanouriakis

Since Specialization

Citations

This map shows the geographic impact of Antonis Fanouriakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonis Fanouriakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonis Fanouriakis more than expected).

Fields of papers citing papers by Antonis Fanouriakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonis Fanouriakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonis Fanouriakis. The network helps show where Antonis Fanouriakis may publish in the future.

Co-authorship network of co-authors of Antonis Fanouriakis

This figure shows the co-authorship network connecting the top 25 collaborators of Antonis Fanouriakis. A scholar is included among the top collaborators of Antonis Fanouriakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonis Fanouriakis. Antonis Fanouriakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silvagni, Ettore, Argyro Repa, Konstantinos Parperis, et al.. (2025). Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study. RMD Open. 11(1). e005118–e005118. 3 indexed citations

Garantziotis, Panagiotis, Dionysis Nikolopoulos, Anastasia Filia, et al.. (2025). Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus. RMD Open. 11(1). e005050–e005050. 2 indexed citations

Karofylakis, Emmanouil, et al.. (2025). Persistent-relapsing SARS-CoV-2 infection following rituximab treatment for autoimmune rheumatic diseases: diagnosis and outcomes. RMD Open. 11(3). e005756–e005756.

Garantziotis, Panagiotis, Ettore Silvagni, Argyro Repa, et al.. (2024). Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the Rheumatic Diseases. 83(4). 464–474. 11 indexed citations

Παππά, Μαρία, Dimitrios T. Boumpas, & Antonis Fanouriakis. (2024). Hydroxychloroquine for all patients with lupus nephritis: yes. Nephrology Dialysis Transplantation. 40(4). 610–613. 1 indexed citations

Nikolopoulos, Dionysis, Christina Adamichou, Pelagia Katsimbri, et al.. (2024). Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation. Lara D. Veeken. 64(5). 2715–2722. 1 indexed citations

Kostopoulou, Myrto, Antonis Fanouriakis, George Βertsias, & Dimitrios T. Boumpas. (2023). Annals of the Rheumatic Diseases collection on lupus nephritis (2019–2022): novel insights and advances in therapy. Annals of the Rheumatic Diseases. 82(6). 729–733. 14 indexed citations

Papastefanakis, Emmanouil, Antonis Fanouriakis, Christina Adamichou, et al.. (2022). The relation of partners’ illness representations to the coping behaviors of patients with inflammatory rheumatic diseases through patients’ illness representation: A dyadic regulation process. Current Psychology. 42(20). 16923–16931. 1 indexed citations

Frangou, Eleni, Panagiotis Garantziotis, Aggelos Banos, et al.. (2022). Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis. Annals of the Rheumatic Diseases. 81(10). 1409–1419. 15 indexed citations

10.

Nikolopoulos, Dionysis, et al.. (2021). First Diagnosis of Systemic Lupus Erythematosus in Hospitalized Patients: Clinical Phenotypes and Pitfalls for the Non-Specialist. The American Journal of Medicine. 135(2). 244–253.e3. 13 indexed citations

11.

Nikolopoulos, Dionysis, Antonis Fanouriakis, & George Βertsias. (2021). Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives. Expert Review of Clinical Immunology. 17(4). 317–329. 18 indexed citations

12.

Adamichou, Christina, Dionysis Nikolopoulos, Argyro Repa, et al.. (2021). Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus. Annals of the Rheumatic Diseases. 80(6). 758–766. 71 indexed citations

13.

Simos, N., Eleftherios Kavroulakis, George Βertsias, et al.. (2021). Anxiety and depression severity in neuropsychiatric SLE are associated with perfusion and functional connectivity changes of the frontolimbic neural circuit: a resting-state f(unctional) MRI study. Lupus Science & Medicine. 8(1). e000473–e000473. 18 indexed citations

14.

Fanouriakis, Antonis, et al.. (2020). Targeted Biologic Therapy for Systemic Lupus Erythematosus: Emerging Pathways and Drug Pipeline. BioDrugs. 34(2). 133–147. 24 indexed citations

15.

Nikolopoulos, Dionysis, Myrto Kostopoulou, Aggelos Banos, et al.. (2020). Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease. Lupus Science & Medicine. 7(1). e000394–e000394. 24 indexed citations

16.

Nikolopoulos, Dionysis, Matilda Papathanasiou, Maria Chondrogianni, et al.. (2020). Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohort. Lara D. Veeken. 60(9). 4166–4174. 7 indexed citations

17.

Fanouriakis, Antonis, Nikolaos Tziolos, George Βertsias, & Dimitrios T. Boumpas. (2020). Update οn the diagnosis and management of systemic lupus erythematosus. Annals of the Rheumatic Diseases. 80(1). 14–25. 434 indexed citations breakdown →

18.

Nikolopoulos, Dionysis, Antonis Fanouriakis, & Dimitrios T. Boumpas. (2019). Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management. SHILAP Revista de lepidopterología. 30(1). 7–15. 42 indexed citations

19.

Adamichou, Christina, Dionysis Nikolopoulos, Alessandra Bortoluzzi, et al.. (2019). In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment. Annals of the Rheumatic Diseases. 79(2). 232–241. 79 indexed citations

20.

Fanouriakis, Antonis & George Βertsias. (2019). Changing paradigms in the treatment of systemic lupus erythematosus. Lupus Science & Medicine. 6(1). e000310–e000310. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact